Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenshun Cheng

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Current Medical Research and Opinion|November 2, 2020
Dandelion and focal crazy paving signs: the lung CT based predictors for evaluation of the severity of coronavirus diseaseXi Zhan, Zhihai Chen, Huijuan Hu, et al.
Frontiers in Pharmacology|March 31, 2022
<i>Dec1</i> Deficiency Ameliorates Pulmonary Fibrosis Through the PI3K/AKT/GSK-3β/β-Catenin Integrated Signaling PathwayXingxing Hu, Menglin Zou, Lan Ni, et al.
Cells|December 11, 2022
Nrf2 Deficiency Exacerbated CLP-Induced Pulmonary Injury and Inflammation through Autophagy- and NF-κB/PPARγ-Mediated Macrophage PolarizationJing Luo, Jin Wang, Jing Zhang, et al.
Frontiers in Medicine|May 27, 2024
Endobronchial ultrasound-guided transbronchial needle aspiration for diagnosing thoracic lesions: a retrospective cohort studyHuibin Liao, Miaojuan Zhu, Ru Li, et al.
Experimental Cell Research|February 5, 2020
Inhibition of the ERK1/2-ubiquitous calpains pathway attenuates experimental pulmonary fibrosis in vivo and in vitroMenglin Zou, Guqin Zhang, Jingfeng Zou, et al.
Clinical and Experimental Medicine|October 20, 2023
Plasma LTBP2 as a potential biomarker in differential diagnosis of connective tissue disease-associated interstitial lung disease and idiopathic pulmonary fibrosis: a pilot studyMenglin Zou, Xingxing Hu, Weiwei Song, et al.
Journal of Cellular Biochemistry|August 23, 2018
CASTOR1 suppresses the progression of lung adenocarcinoma and predicts poor prognosisXuefeng Zhou, Zhenshun Cheng, Hao Chen, et al.
BMC Microbiology|February 21, 2026
A target-guided drug repurposing strategy for antibacterial discoveryDongdong Zhang, Haotian Li, Anqiang Ye, et al.
Frontiers in Pharmacology|March 17, 2025
Identification of glycolysis-related gene signatures for prognosis and therapeutic targeting in idiopathic pulmonary fibrosisHan Gao, Zhongyi Sun, Xingxing Hu, et al.
Communications Biology|January 20, 2025
Human epididymis protein 4-annexin II binding promotes aberrant epithelial-fibroblast crosstalk in pulmonary fibrosisWeishuai Zheng, Menglin Zou, Xingxing Hu, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Current Medical Research and Opinion|November 2, 2020
Dandelion and focal crazy paving signs: the lung CT based predictors for evaluation of the severity of coronavirus diseaseXi Zhan, Zhihai Chen, Huijuan Hu, et al.
Frontiers in Pharmacology|March 31, 2022
<i>Dec1</i> Deficiency Ameliorates Pulmonary Fibrosis Through the PI3K/AKT/GSK-3β/β-Catenin Integrated Signaling PathwayXingxing Hu, Menglin Zou, Lan Ni, et al.
Cells|December 11, 2022
Nrf2 Deficiency Exacerbated CLP-Induced Pulmonary Injury and Inflammation through Autophagy- and NF-κB/PPARγ-Mediated Macrophage PolarizationJing Luo, Jin Wang, Jing Zhang, et al.
Frontiers in Medicine|May 27, 2024
Endobronchial ultrasound-guided transbronchial needle aspiration for diagnosing thoracic lesions: a retrospective cohort studyHuibin Liao, Miaojuan Zhu, Ru Li, et al.
Experimental Cell Research|February 5, 2020
Inhibition of the ERK1/2-ubiquitous calpains pathway attenuates experimental pulmonary fibrosis in vivo and in vitroMenglin Zou, Guqin Zhang, Jingfeng Zou, et al.
Clinical and Experimental Medicine|October 20, 2023
Plasma LTBP2 as a potential biomarker in differential diagnosis of connective tissue disease-associated interstitial lung disease and idiopathic pulmonary fibrosis: a pilot studyMenglin Zou, Xingxing Hu, Weiwei Song, et al.
Journal of Cellular Biochemistry|August 23, 2018
CASTOR1 suppresses the progression of lung adenocarcinoma and predicts poor prognosisXuefeng Zhou, Zhenshun Cheng, Hao Chen, et al.
BMC Microbiology|February 21, 2026
A target-guided drug repurposing strategy for antibacterial discoveryDongdong Zhang, Haotian Li, Anqiang Ye, et al.
Frontiers in Pharmacology|March 17, 2025
Identification of glycolysis-related gene signatures for prognosis and therapeutic targeting in idiopathic pulmonary fibrosisHan Gao, Zhongyi Sun, Xingxing Hu, et al.
Communications Biology|January 20, 2025
Human epididymis protein 4-annexin II binding promotes aberrant epithelial-fibroblast crosstalk in pulmonary fibrosisWeishuai Zheng, Menglin Zou, Xingxing Hu, et al.
Pageof 7